Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects
Roni F. Rayes, Jack G. Mouhanna, Ioana Nicolau, France Bourdeau, Betty Giannias, Simon Rousseau, Daniela Quail, Logan Walsh, Veena Sangwan, Nicholas Bertos, Jonathan Cools-Lartigue, Lorenzo E. Ferri, Jonathan D. Spicer
Roni F. Rayes, Jack G. Mouhanna, Ioana Nicolau, France Bourdeau, Betty Giannias, Simon Rousseau, Daniela Quail, Logan Walsh, Veena Sangwan, Nicholas Bertos, Jonathan Cools-Lartigue, Lorenzo E. Ferri, Jonathan D. Spicer
View: Text | PDF
Research Article Oncology

Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects

  • Text
  • PDF
Abstract

Targeting the dynamic tumor immune microenvironment (TIME) can provide effective therapeutic strategies for cancer. Neutrophils are the predominant leukocyte population in mice and humans, and mounting evidence implicates these cells during tumor growth and metastasis. Neutrophil extracellular traps (NETs) are networks of extracellular neutrophil DNA fibers that are capable of binding tumor cells to support metastatic progression. Here, we demonstrate that circulating NET levels are elevated in advanced esophageal, gastric, and lung cancer patients compared with local cancers and healthy controls. Using preclinical murine models of lung and colon cancer, in combination with intravital video microscopy, we show that NETs functionally regulate disease progression and that blocking NETosis through multiple strategies significantly inhibits spontaneous metastasis to the lung and liver. Furthermore, we show how inhibiting tumor-induced NETs decreases cancer cell adhesion to liver sinusoids following intrasplenic injection — a mechanism previously thought to be driven primarily by exogenous stimuli. Thus, in addition to neutrophil abundance, the functional contribution of NETosis within the TIME has critical translational relevance and represents a promising target to impede metastatic dissemination.

Authors

Roni F. Rayes, Jack G. Mouhanna, Ioana Nicolau, France Bourdeau, Betty Giannias, Simon Rousseau, Daniela Quail, Logan Walsh, Veena Sangwan, Nicholas Bertos, Jonathan Cools-Lartigue, Lorenzo E. Ferri, Jonathan D. Spicer

×

Figure 1

Circulating NET levels in esophagogastric and lung adenocarcinoma patients.

Options: View larger image (or click on image) Download as PowerPoint
Circulating NET levels in esophagogastric and lung adenocarcinoma patien...
(A) NET levels (normalized to the average NET level of healthy individuals, labeled as normal) obtained by the NETs ELISA are shown for patients with local cancer (n = 28), compared with both patients with advanced cancer (n = 32) and with healthy individuals (labeled as normal; n = 15). A Kruskal-Wallis test was used to calculate significance because the data were not normally distributed, as assessed by the Kolmogorov-Smirnov test. (B) NET levels (normalized to the average NET level of overall stage I and -II) for esophagogastric adenocarcinoma patients are shown for overall stage I and -II (n = 12) and stage III and -IV (n = 25). (C) NET levels (normalized to the average NET level of overall stage I) for lung adenocarcinoma patients shown plotted for overall stage I (n = 16) and stage II and -III (n = 7). A Student t test was used to assess statistical significance for B and C. Mean ± SEM is shown for all panels. *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts